ECARX HOLDINGS INC-CL A (ECX) Stock Fundamental Analysis

NASDAQ:ECX • KYG292011031

1.65 USD
-0.12 (-6.78%)
At close: Feb 13, 2026
1.65 USD
0 (0%)
After Hours: 2/13/2026, 8:04:45 PM
Fundamental Rating

1

Overall ECX gets a fundamental rating of 1 out of 10. We evaluated ECX against 41 industry peers in the Automobile Components industry. ECX has a bad profitability rating. Also its financial health evaluation is rather negative. ECX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ECX had negative earnings in the past year.
  • In the past 5 years ECX always reported negative net income.
  • In the past 5 years ECX always reported negative operating cash flow.
ECX Yearly Net Income VS EBIT VS OCF VS FCFECX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

  • The Return On Assets of ECX (-14.59%) is worse than 76.74% of its industry peers.
Industry RankSector Rank
ROA -14.59%
ROE N/A
ROIC N/A
ROA(3y)-28.87%
ROA(5y)-28.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECX Yearly ROA, ROE, ROICECX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500

1.3 Margins

  • ECX has a better Gross Margin (73.41%) than 100.00% of its industry peers.
  • ECX's Gross Margin has declined in the last couple of years.
  • ECX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.97%
GM growth 5YN/A
ECX Yearly Profit, Operating, Gross MarginsECX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40

0

2. Health

2.1 Basic Checks

  • ECX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ECX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ECX Yearly Shares OutstandingECX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M
ECX Yearly Total Debt VS Total AssetsECX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.76, we must say that ECX is in the distress zone and has some risk of bankruptcy.
  • ECX has a worse Altman-Z score (0.76) than 65.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACCN/A
WACC8.39%
ECX Yearly LT Debt VS Equity VS FCFECX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that ECX may have some problems paying its short term obligations.
  • ECX has a worse Current ratio (0.54) than 95.35% of its industry peers.
  • A Quick Ratio of 0.44 indicates that ECX may have some problems paying its short term obligations.
  • ECX's Quick ratio of 0.44 is on the low side compared to the rest of the industry. ECX is outperformed by 95.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.44
ECX Yearly Current Assets VS Current LiabilitesECX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B

1

3. Growth

3.1 Past

  • ECX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.26%, which is quite impressive.
EPS 1Y (TTM)47.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 67.47% on average over the next years. This is a very strong growth
  • ECX is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -27.30% yearly.
EPS Next Y141.49%
EPS Next 2Y67.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year32.55%
Revenue Next 2Y31.9%
Revenue Next 3Y-36.36%
Revenue Next 5Y-27.3%

3.3 Evolution

ECX Yearly Revenue VS EstimatesECX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ECX Yearly EPS VS EstimatesECX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 1 -1 -2

4

4. Valuation

4.1 Price/Earnings Ratio

  • ECX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 2.65 indicates a rather cheap valuation of ECX.
  • Based on the Price/Forward Earnings ratio, ECX is valued cheaper than 100.00% of the companies in the same industry.
  • ECX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 2.65
ECX Price Earnings VS Forward Price EarningsECX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECX Per share dataECX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ECX's earnings are expected to grow with 67.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ECX!.
Industry RankSector Rank
Dividend Yield 0%

ECARX HOLDINGS INC-CL A

NASDAQ:ECX (2/13/2026, 8:04:45 PM)

After market: 1.65 0 (0%)

1.65

-0.12 (-6.78%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12
Earnings (Next)04-21
Inst Owners6.71%
Inst Owner Change-89.97%
Ins Owners3.35%
Ins Owner Change0%
Market Cap588.64M
Revenue(TTM)N/A
Net Income(TTM)-74.03M
Analysts82.5
Price Target3.88 (135.15%)
Short Float %2.4%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-67.35%
Min EPS beat(2)-234.7%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)-26.64%
Min EPS beat(4)-234.7%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-46.55%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24.66%
Min Revenue beat(2)-31.55%
Max Revenue beat(2)-17.77%
Revenue beat(4)2
Avg Revenue beat(4)-7.71%
Min Revenue beat(4)-31.55%
Max Revenue beat(4)10.2%
Revenue beat(8)4
Avg Revenue beat(8)-23.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)168.34%
EPS NY rev (1m)9.08%
EPS NY rev (3m)-16.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.65
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)0.62
Fwd EY37.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.97
BVpS-0.83
TBVpS-0.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.41%
FCFM N/A
ROA(3y)-28.87%
ROA(5y)-28.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.97%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover4.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.44
Altman-Z 0.76
F-ScoreN/A
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)112.87%
Cap/Depr(5y)115.42%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
EPS Next Y141.49%
EPS Next 2Y67.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.3%
Revenue Next Year32.55%
Revenue Next 2Y31.9%
Revenue Next 3Y-36.36%
Revenue Next 5Y-27.3%
EBIT growth 1Y88.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year90.43%
EBIT Next 3Y42.31%
EBIT Next 5Y16.83%
FCF growth 1Y57.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.1%
OCF growth 3YN/A
OCF growth 5YN/A

ECARX HOLDINGS INC-CL A / ECX FAQ

What is the ChartMill fundamental rating of ECARX HOLDINGS INC-CL A (ECX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ECX.


What is the valuation status for ECX stock?

ChartMill assigns a valuation rating of 4 / 10 to ECARX HOLDINGS INC-CL A (ECX). This can be considered as Fairly Valued.


Can you provide the profitability details for ECARX HOLDINGS INC-CL A?

ECARX HOLDINGS INC-CL A (ECX) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ECX stock?

The Earnings per Share (EPS) of ECARX HOLDINGS INC-CL A (ECX) is expected to grow by 141.49% in the next year.